SE348462B - - Google Patents

Info

Publication number
SE348462B
SE348462B SE08945/67A SE894567A SE348462B SE 348462 B SE348462 B SE 348462B SE 08945/67 A SE08945/67 A SE 08945/67A SE 894567 A SE894567 A SE 894567A SE 348462 B SE348462 B SE 348462B
Authority
SE
Sweden
Application number
SE08945/67A
Inventor
H Keberle
J Faigle
M Wilhelm
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH853763A external-priority patent/CH446376A/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE348462B publication Critical patent/SE348462B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE08945/67A 1963-07-09 1964-07-08 SE348462B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH853763A CH446376A (de) 1963-07-09 1963-07-09 Verfahren zur Herstellung neuer Aminosäuren
CH672964 1964-05-22

Publications (1)

Publication Number Publication Date
SE348462B true SE348462B (sv) 1972-09-04

Family

ID=25700075

Family Applications (4)

Application Number Title Priority Date Filing Date
SE8340/64A SE333151B (sv) 1963-07-09 1964-07-08 Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav
SE08945/67A SE348462B (sv) 1963-07-09 1964-07-08
SE08944/67A SE348461B (sv) 1963-07-09 1964-07-08
SE08943/67A SE348460B (sv) 1963-07-09 1964-07-08

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8340/64A SE333151B (sv) 1963-07-09 1964-07-08 Foerfarande foer framstaellning av nya centralt haemmande verkande aminosyror och salter daerav

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE08944/67A SE348461B (sv) 1963-07-09 1964-07-08
SE08943/67A SE348460B (sv) 1963-07-09 1964-07-08

Country Status (9)

Country Link
US (1) US3471548A (sv)
BE (1) BE650258A (sv)
BR (1) BR6460727D0 (sv)
CH (1) CH449645A (sv)
DE (1) DE1493536B1 (sv)
ES (1) ES301814A1 (sv)
FR (2) FR3692M (sv)
GB (1) GB1017439A (sv)
SE (4) SE333151B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3947579A (en) * 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
US3978216A (en) * 1974-06-03 1976-08-31 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US4084000A (en) * 1975-07-16 1978-04-11 Nelson Research And Development Company Method of treating schizophrenia
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
NL8006135A (nl) * 1980-11-10 1982-06-01 Univ Erasmus Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents
WO1997022578A1 (en) * 1995-12-20 1997-06-26 Farmarc Nederland B.V. A process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
BR9710536A (pt) 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
EP1337271B1 (en) 2000-11-30 2004-11-03 Pfizer Products Inc. Combination of gaba agonists and sorbitol dehydrogenase inhibitors
EE200300249A (et) 2000-11-30 2003-10-15 Pfizer Products Inc. GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
BRPI0410271A (pt) * 2003-05-16 2006-05-16 Pfizer Prod Inc combinações terapêuticas de antipsicóticos atìpicos com moduladores de gaba, anticonvulsivantes ou benzodiazepinas
PT1660440E (pt) * 2003-08-20 2012-05-15 Xenoport Inc Pró-fármacos de aciloxialquilcarbamato, métodos de síntese e utilização
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
EP1737466A1 (en) * 2004-01-29 2007-01-03 Pfizer Products Inc. COMBINATION OF y-AMINOBUTYRIC ACID MODULATORS AND 5-HT-1b RECEPTOR ANTAGONISTS
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
WO2008018275A1 (fr) 2006-08-11 2008-02-14 National University Corporation Nagoya University Agent anti-obésité et son utilisation
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP2010521453A (ja) * 2007-03-15 2010-06-24 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 新規プロドラッグ
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
US20180208544A1 (en) 2015-07-13 2018-07-26 Piramal Enterprises Limited An improved process for the preparation of baclofen and its intermediate
CN106187794A (zh) * 2016-07-12 2016-12-07 安徽省逸欣铭医药科技有限公司 一种巴氯芬的绿色工业化生产方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125583A (en) * 1964-03-17 Hjnc oxchaxohxchc o oh

Also Published As

Publication number Publication date
SE348460B (sv) 1972-09-04
SE348461B (sv) 1972-09-04
GB1017439A (en) 1966-01-19
BR6460727D0 (pt) 1973-08-02
DE1493536B1 (de) 1971-10-14
SE333151B (sv) 1971-03-08
CH449645A (de) 1968-01-15
US3471548A (en) 1969-10-07
BE650258A (sv) 1965-01-08
FR3692M (fr) 1965-11-15
ES301814A1 (es) 1965-01-01
FR3677M (fr) 1965-11-08

Similar Documents

Publication Publication Date Title
AR142945A1 (sv)
AT260747B (sv)
BE627012A (sv)
BE623220A (sv)
BE627025A (sv)
BE626590A (sv)
BE533484A (sv)
BE547422A (sv)
BE571209A (sv)
BE626803A (sv)
BE603935A (sv)
BE608372A (sv)
BE612803A (sv)
BE614220A (sv)
BE616247A (sv)
BE616830A (sv)
BE616967A (sv)
BE619061A (sv)
BE620325A (sv)
BE621232A (sv)
BE621517A (sv)
BE622160A (sv)
BE623117A (sv)
BE623162A (sv)
BE626358A (sv)